Rapid increase of interleukin-10 plasma levels after combined auxiliary liver-kidney transplantation in presensitized patients

Transplantation

Volumn 98, Issue 2, 2014, Pages 208-215

  Ingelsten, Madeleine ^a   Gustafsson, Karin ^a   Olausson, Michael ^a   Haraldsson, Börje ^a   Karlsson Parra, Alex ^b   Nyström, Jenny ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Allograft rejection; Chemokine; Dendritic cells; Interleukin 10; Tolerance

Indexed keywords

CELLS, CULTURED; CHEMOKINE CXCL10; CHEMOKINE CXCL11; CHEMOKINE CXCL9; DENDRITIC CELLS; GRAFT REJECTION; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-1BETA; KIDNEY TRANSPLANTATION; KILLER CELLS, NATURAL; LIVER TRANSPLANTATION; PHENOTYPE; T-LYMPHOCYTES; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84904611519     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000038     Document Type: Article

References (21)

1. Larsen CP, Morris PJ, Austyn JM. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J Exp Med 1990; 171: 307.
2. Gordon RD, Fung JJ, Markus B, et al. The antibody crossmatch in liver transplantation. Surgery 1986; 100: 705.
3. Gonwa TA, Nery JR, Husberg BS, et al. Simultaneous liver and renal transplantation in man. Transplantation 1988; 46: 690.
4. Vogel W, Steiner E, Kornberger R, et al. Preliminary results with combined hepatorenal allografting. Transplantation 1988; 45: 491.
5. Rasmussen A, Davies HF, Jamieson NV, et al. Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation 1995; 59: 919.
6. Leca N, Warner P, Bakthavatsalam R, et al. Outcomes of simultaneous liver and kidney transplantation in relation to a high level of preformed donor-specific antibodies. Transplantation 2013; 96: 914.
7. Olausson M, Mjornstedt L, Norden G, et al. Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients. Am J Transplant 2007; 7: 130.
8. Le Moine O, Marchant A, Durand F, et al. Systemic release of interleukin-10 during orthotopic liver transplantation. Hepatology 1994; 20: 889.
9. Ingelsten M, Gustafsson K, Oltean M, et al. Is indoleamine 2, 3-dioxygenase important for graft acceptance in highly sensitized patients after combined auxiliary liver-kidney transplantation? Transplantation 2009; 88: 911.
10. Weimer R, Mytilineos J, Feustel A, et al. Mycophenolate mofetil-based immunosuppression and cytokine genotypes: effects on monokine secretion and antigen presentation in long-term renal transplant recipients. Transplantation 2003; 75: 2090.
11. Chhabra D, Grafals M, Cabral B, et al. Late conversion of tacrolimus to sirolimus in a prednisone-free immunosuppression regimen in renal transplant patients. Clin Transplant 2010; 24: 199.
12. Faulkner L, Buchan G, Baird M. Interleukin-10 does not affect phagocytosis of particulate antigen by bone marrow-derived dendritic cells but does impair antigen presentation. Immunology 2000; 99: 523.
13. Haase C, Jorgensen TN, Michelsen BK. Both exogenous and endogenous interleukin-10 affects the maturation of bone-marrow-derived dendritic cells in vitro and strongly influences T-cell priming in vivo. Immunology 2002; 107: 489.
14. Morel AS, Quaratino S, Douek DC, et al. Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step. Eur J Immunol 1997; 27: 26.
15. Rabin RL, Park MK, Liao F, et al. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. J Immunol 1999; 162: 3840.
16. Kitchens WH, Uehara S, Chase CM, et al. The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation 2006; 81: 811.
17. Martin-Fontecha A, Thomsen LL, Brett S, et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004; 5: 1260.
18. Kos FJ, Engleman EG. Requirement for natural killer cells in the induction of cytotoxic T cells. J Immunol 1995; 155: 578.
19. Dai Z, Konieczny BT, Baddoura FK, et al. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice. J Immunol 1998; 161: 1659.
20. Kang HG, Zhang D, Degauque N, et al. Effects of cyclosporine on transplant tolerance: the role of IL-2. Am J Transplant 2007; 7: 1907.
21. Furtado GC, de Lafaille MAC, Kutchukhidze N, et al. Interleukin 2 signaling is required for CD4+ regulatory T cell function. J Exp Med 2002; 196: 851.